Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Alpelisib|DRUG: Sacituzumab govitecan
Sponsor: University of Kansas Medical Center
Collaborators: Novartis Pharmaceuticals|Gilead Sciences